TRDA insider trading
NasdaqGM HealthcareEntrada Therapeutics, Inc.: insider trade history from SEC Form 4 filings.
About Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Company website: www.entradatx.com
TRDA insider activity at a glance
FilingIQ tracks 438 insider transactions for TRDA in filings since Nov 4, 2021. The most recent transaction is dated Sep 9, 2026.
Across the full history, 61 open-market purchases
and 217 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on TRDA insider trades is 48.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest TRDA Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for TRDA?
- FilingIQ tracks 438 Form 4 insider transactions for TRDA (Entrada Therapeutics, Inc.), covering filings from Nov 4, 2021 onwards. 37 of those are dated within the last 90 days.
- Are TRDA insiders net buyers or net sellers?
- Across the full Form 4 history for TRDA, 61 transactions (14%) were open-market purchases and 217 (50%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does TRDA insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is TRDA in?
- Entrada Therapeutics, Inc. (TRDA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $452.90M.
Methodology & sources
Every TRDA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.